Yusuf A, Amri M, Ugusman A, A Hamid A, Abd Rahman I, Mokhtar M
Biomedicines. 2025; 13(2).
PMID: 40002703
PMC: 11853574.
DOI: 10.3390/biomedicines13020289.
Maeda T, Ono M, Osako T, Chiba T, Baba S, Iesato A
Cancer Med. 2025; 14(4):e70666.
PMID: 39967410
PMC: 11836529.
DOI: 10.1002/cam4.70666.
Jia Y, Liu J, Shi J, Zhang C, Wang X, Zhao L
Oncol Rep. 2025; 53(2.
PMID: 39749700
PMC: 11718434.
DOI: 10.3892/or.2024.8861.
Kouvaraki M, Zerdes I, Sifakis E, Sarafidis M, Matikas A, Tzoras E
Int J Cancer. 2024; 156(8):1621-1633.
PMID: 39729390
PMC: 11826144.
DOI: 10.1002/ijc.35319.
Ablinger C, Neureiter D, Mahr T, Mayr C, Kiesslich T, Maeding N
Cancer Biol Ther. 2024; 25(1):2439057.
PMID: 39668430
PMC: 11789727.
DOI: 10.1080/15384047.2024.2439057.
TRIM4 modulates the ubiquitin-mediated degradation of hnRNPDL and weakens sensitivity to CDK4/6 inhibitor in ovarian cancer.
Che X, Guan X, Ruan Y, Shen L, Shen Y, Liu H
Front Med. 2024; 19(1):121-133.
PMID: 39643799
DOI: 10.1007/s11684-024-1103-5.
Trans, trans-2,4-decadienal, a lipid peroxidation product, aggravates insulin resistance in obese mice by promoting adipose inflammation.
Hu Y, Zeng X, Luo Y, Pei X, Zhou D, Zhu B
Food Sci Nutr. 2024; 12(9):6398-6410.
PMID: 39554331
PMC: 11561848.
DOI: 10.1002/fsn3.4273.
Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score.
Arolt C, Scheel A, Dugan M, Wild R, Richartz V, Holz B
NPJ Precis Oncol. 2024; 8(1):259.
PMID: 39528799
PMC: 11554772.
DOI: 10.1038/s41698-024-00744-1.
pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post-Initiation of Androgen Deprivation Therapy.
Bialas P, Kobayashi T, Hellsten R, Krzyzanowska A, Persson M, Marginean F
Prostate. 2024; 85(3):252-264.
PMID: 39523927
PMC: 11720397.
DOI: 10.1002/pros.24820.
The Prognostic Significance of CTSV Expression in Patients with Hepatocellular Carcinoma.
He Y, Xu M, Zhou C, Dong Q, Hu Z, Ren N
Int J Gen Med. 2024; 17:4867-4881.
PMID: 39465186
PMC: 11512791.
DOI: 10.2147/IJGM.S467179.
Upregulation of PRRX2 by silencing Marveld3 as a protective mechanism against radiation-induced ferroptosis in skin cells.
Cao J, Wu M, Mo W, Zhao M, Gu L, Wang X
Mol Med. 2024; 30(1):182.
PMID: 39434056
PMC: 11494952.
DOI: 10.1186/s10020-024-00958-w.
Increased PRP19 in Hepatocyte Impedes B Cell Function to Promote Hepatocarcinogenesis.
Liu Z, Lin X, Zhang D, Guo D, Tang W, Yu X
Adv Sci (Weinh). 2024; 11(46):e2407517.
PMID: 39422063
PMC: 11633487.
DOI: 10.1002/advs.202407517.
Synergistic Enhancement of 5-Fluorouracil Chemotherapeutic Efficacy by Taurine in Colon Cancer Rat Model.
Jornada D, Boreski D, Chiba D, Ligeiro D, Luz M, Gabriel E
Nutrients. 2024; 16(18).
PMID: 39339648
PMC: 11434803.
DOI: 10.3390/nu16183047.
Supraphysiological Dose of Testosterone Impairs the Expression and Distribution of Sex Steroid Receptors during Endometrial Receptivity Development in Female Sprague-Dawley Rats.
Yusuf A, Amri M, Ugusman A, A Hamid A, Mokhtar M
Int J Mol Sci. 2024; 25(18).
PMID: 39337689
PMC: 11432676.
DOI: 10.3390/ijms251810202.
BAG2, MAD2L1, and MDK are cancer-driver genes and candidate targets for novel therapies in malignant pleural mesothelioma.
Bisceglia L, Morani F, Guerrieri L, Santoni-Rugiu E, Cakilkaya P, Scatena C
Cancer Gene Ther. 2024; 31(11):1708-1720.
PMID: 39300217
PMC: 11567880.
DOI: 10.1038/s41417-024-00805-4.
IGFBP2 functions as an endogenous protector against hepatic steatosis via suppression of the EGFR-STAT3 pathway.
Zhai T, Cai L, Jia X, Xia M, Bian H, Gao X
Mol Metab. 2024; 89:102026.
PMID: 39299533
PMC: 11474195.
DOI: 10.1016/j.molmet.2024.102026.
Dissection of triple-negative breast cancer microenvironment and identification of potential therapeutic drugs using single-cell RNA sequencing analysis.
Cheng W, Mi W, Wang S, Wang X, Jiang H, Chen J
J Pharm Anal. 2024; 14(8):100975.
PMID: 39263352
PMC: 11388705.
DOI: 10.1016/j.jpha.2024.100975.
A novel assessment of whole-mount Gleason grading in prostate cancer to identify candidates for radical prostatectomy: a machine learning-based multiomics study.
Ning J, Spielvogel C, Haberl D, Trachtova K, Stoiber S, Rasul S
Theranostics. 2024; 14(12):4570-4581.
PMID: 39239512
PMC: 11373617.
DOI: 10.7150/thno.96921.
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations.
Piha-Paul S, Tseng C, Leung C, Yuan Y, Karp D, Subbiah V
NPJ Precis Oncol. 2024; 8(1):166.
PMID: 39085400
PMC: 11291882.
DOI: 10.1038/s41698-024-00634-6.
TET2-STAT3-CXCL5 nexus promotes neutrophil lipid transfer to fuel lung adeno-to-squamous transition.
Xue Y, Chen Y, Sun S, Tong X, Chen Y, Tang S
J Exp Med. 2024; 221(7).
PMID: 38805014
PMC: 11129275.
DOI: 10.1084/jem.20240111.